ATR logo

APTARGROUP INC

ATRNYSE
πŸ† #951 by market capEarnings Oct 29 Β· PostUS Equity
$127.21β–² $0.75 (+0.59%)
Pre-market Β· at close
πŸ””
Track ATR
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.6%
7dβ–Ό 0.8%
14dβ–² 2.4%
30dβ–² 3.3%
ytdβ–² 4.4%
1yβ–² 2.4%
🏦Market Cap
$8.09B
Small Cap
πŸ“ˆRevenue Growth (YoY)
8.9%
Slowing
πŸ“ŠGross Margin
36.1%
Healthy
πŸ’΅FCF Margin
7.8%
Moderate
βš–οΈP/S Ratio
2.0x
Cheap
Otter Score
76
Strong

Trading Snapshot

Day Range
$125.70 – $127.27
52-Week Range
$103.23 – $146.91
Volume (shares)
23,358
Avg Volume (shares)
β€”
Shares Outstanding
63.6M
Next Earnings
2026-10-29

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
β€”
P/E Ratio
22.2
P/S Ratio
2.0x
EPS (TTM)
$5.54
Dividend Yield
1.53%
Dilution (1yr)
βˆ’3.1%
ATR logo

APTARGROUP INC

ATR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3.8Bβ–² +5.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
29.6%β–Ό βˆ’21.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$512Mβ–² +3.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$300Mβ–Ό βˆ’14.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
65.8Mβ–Ό βˆ’3.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$1.1Bβ–Ό βˆ’$276M YoY
StockOtter Β· stockotter.space

About APTARGROUP INC

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
76/100

Analyst Ratings

β“˜
Consensus
Buy
13 analysts
Strong Buy5
Buy6
Hold2
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.